Menu
← Oncology Approval Tracker
FDA DECISION ·
Romidepsin injection
romidepsin · Teva Pharmaceuticals USA
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with peripheral T-cell lymphoma who had received at least one prior therapy.
LAMPGEN ANALYSIS
Why it matters
The liquid injection formulation carried accelerated approval for this peripheral lymphoma indication, which FDA later withdrew.
What research teams should watch
Keep the historical peripheral lymphoma action distinct from the cutaneous lymphoma indication for the same product.
PRIMARY RECORDS